Capstone Investment Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$345K Buy
3,418
+331
+11% +$34.3K ﹤0.01% 1391
2026
Q1
$299K Buy
+3,087
New +$317K ﹤0.01% 1365
2025
Q4
– Sell
-6,035
Closed -$767K – 1728
2025
Q3
$767K Buy
6,035
+2,611
+76% +$311K ﹤0.01% 1137
2025
Q2
$420K Buy
+3,424
New +$391K ﹤0.01% 1221
2024
Q2
– Sell
-18,185
Closed -$1.5M – 2182
2024
Q1
$1.5M Buy
+18,185
New +$1.33M 0.01% 918
2023
Q4
– Sell
-10,687
Closed -$718K – 2180
2023
Q3
$718K Buy
+10,687
New +$735K ﹤0.01% 1134
2016
Q3
– Sell
-9,176
Closed -$283K – 782
2016
Q2
$283K Buy
+9,176
New +$287K 0.01% 568

Other funds holding EHC

Capstone Investment Advisors's EHC Position: Q2 2026 in Review

Capstone Investment Advisors increased its Encompass Health (EHC) stake by 11% in Q2 2026, buying an estimated $34.3K and bringing the position to 3,418 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Capstone Investment Advisors first reported a position in EHC in Q2 2016 and has held it in 7 quarters since. The position peaked at $1.5M in Q1 2024. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Capstone Investment Advisors held 3,418 shares of Encompass Health worth $345K as of Q2 2026.
  • Capstone Investment Advisors bought 331 Encompass Health shares in Q2 2026, an estimated $34.3K.
  • Encompass Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1391 holding.
  • Capstone Investment Advisors first reported a position in Encompass Health in Q2 2016 and has held it in 7 quarters since.
  • Capstone Investment Advisors's Encompass Health position peaked at $1.5M in Q1 2024.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.